Concepedia

Frances Potjewyd

FP

Statistics

Publications

10

Citations

563

H-Index

10

Active since

2014

Affiliations

University of North Carolina at Chapel Hill(Current)

University of Strathclyde

GlaxoSmithKline (United Kingdom)

The Netherlands Cancer Institute

GlaxoSmithKline (Ireland)

Frances Potjewyd is an author at University of North Carolina at Chapel Hill specializing in life sciences, drug discovery, and molecular biology.

Publications per year

2014–2022

10

Publications

10

Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical Degrader

Frances Potjewyd, Anne‐Marie W. Turner, Joshua Beri et al. · Cell chemical biology · 2019 · 177 citations · Full text

, , +6

TBK1 Is a Synthetic Lethal Target in Cancer with <i>VHL</i> Loss

Lianxin Hu, Haibiao Xie, Xijuan Liu et al. · Cancer Discovery · 2019 · 108 citations · Full text

, , +17

Assessing the Cell Permeability of Bivalent Chemical Degraders Using the Chloroalkane Penetration Assay

Caroline A. Foley, Frances Potjewyd, Kelsey N. Lamb et al. · ACS Chemical Biology · 2019 · 94 citations · Full text

, , +15

Rational Design of Autotaxin Inhibitors by Structural Evolution of Endogenous Modulators

Willem‐Jan Keune, Frances Potjewyd, Tatjana Heidebrecht et al. · Journal of Medicinal Chemistry · 2017 · 41 citations · Full text

, , +17

Structure–Activity Relationships of Small Molecule Autotaxin Inhibitors with a Discrete Binding Mode

Lisa Miller, Willem‐Jan Keune, Diana Castagna et al. · Journal of Medicinal Chemistry · 2016 · 37 citations · Full text

, , +17

1–5 of 10